You need to enable JavaScript to run this app.
Recon: US FDA joins global regulators investigating contaminated cough syrup; AstraZeneca’s Evusheld no longer authorized in the US
Recon
Joanne S. Eglovitch
Global
ReconJoanne S. Eglovitch
GlobalReconJoanne S. EglovitchGlobal